TY - JOUR
T1 - Body Temperature, Heart Rate, and Short-Term Outcome of Cooled Infants
AU - Tsuda, K.
AU - Iwata, S.
AU - Mukai, T.
AU - Shibasaki, J.
AU - Takeuchi, A.
AU - Ioroi, T.
AU - Sano, H.
AU - Yutaka, N.
AU - Takahashi, A.
AU - Takenouchi, T.
AU - Osaga, S.
AU - Tokuhisa, T.
AU - Takashima, S.
AU - Sobajima, H.
AU - Tamura, M.
AU - Hosono, S.
AU - Nabetani, M.
AU - Iwata, O.
N1 - Funding Information:
The authors are grateful to the staff of participating centers for their contribution to the data collection, and the infants and their parents for sharing the clinical information. This work was supported by the Japan Society of Perinatal and Neonatal Medicine, and the Ministry of Health, Labour and Welfare, Japan (H27-001, Special research in perinatal medicine). Dr. Tsuda is funded by the Japan Science and Technology Agency and the Ministry of Education, Culture, Sports, Science and Technology (Grant-in-Aid for Scientific Research B26860856). Dr. S. Iwata was funded by the Japan Science and Technology Agency and the Ministry of Education, Culture, Sports, Science and Technology (Grant-in-Aid for Scientific Research C15K09733). Dr. Takeuchi was funded by the Japan Society for the Promotion of Science (Grant-in-Aid for Scientific Research C15K09737). Dr. Takenouchi was funded by Japan Society for the Promotion of Science (Grant-in-Aid for Scientific Research C16K09974 and B17H04232). Dr. O. Iwata was funded by the Japan Science and Technology Agency and the Ministry of Education, Culture, Sports, Science and Technology (Grant-in-Aid for Scientific Research C16K09005). The funding organization had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the article; and decision to submit the article for publication.
Publisher Copyright:
© Kennosuke Tsuda et al., 2018; Published by Mary Ann Liebert, Inc. 2018.
PY - 2019/3
Y1 - 2019/3
N2 - Therapeutic hypothermia following neonatal encephalopathy is neuroprotective. However, approximately one in two cooled infants still die or develop permanent neurological impairments. Further understanding of variables associated with the effectiveness of cooling is important to improve the therapeutic regimen. To identify clinical factors associated with short-term outcomes of cooled infants, clinical data of 509 cooled infants registered to the Baby Cooling Registry of Japan between 2012 and 2014 were evaluated. Independent variables of death during the initial hospitalization and survival discharge from the cooling hospital at ≤28 days of life were assessed. Death was associated with higher Thompson scores at admission (p < 0.001); higher heart rates after 3-72 hours of cooling (p < 0.001); and higher body temperature after 24 hours of cooling (p = 0.002). Survival discharge was associated with higher 10 minutes Apgar scores (p < 0.001); higher blood pH and base excess (both p < 0.001); lower Thompson scores (at admission and after 24 hours of cooling; both p < 0.001); lower heart rates at initiating cooling (p = 0.003) and after 24 hours of cooling (p < 0.001) and lower average values after 3-72 hours of cooling (p < 0.001); higher body temperature at admission (p < 0.001); and lower body temperature after 24 hours and lower mean values after 3-72 hours of cooling (both p < 0.001). Survival discharge was best explained by higher blood pH (p < 0.05), higher body temperature at admission (p < 0.01), and lower body temperature and heart rate after 24 hours of cooling (p < 0.01 and <0.001, respectively). Lower heart rate, higher body temperature at admission, and lower body temperature during cooling were associated with favorable short-term outcomes.
AB - Therapeutic hypothermia following neonatal encephalopathy is neuroprotective. However, approximately one in two cooled infants still die or develop permanent neurological impairments. Further understanding of variables associated with the effectiveness of cooling is important to improve the therapeutic regimen. To identify clinical factors associated with short-term outcomes of cooled infants, clinical data of 509 cooled infants registered to the Baby Cooling Registry of Japan between 2012 and 2014 were evaluated. Independent variables of death during the initial hospitalization and survival discharge from the cooling hospital at ≤28 days of life were assessed. Death was associated with higher Thompson scores at admission (p < 0.001); higher heart rates after 3-72 hours of cooling (p < 0.001); and higher body temperature after 24 hours of cooling (p = 0.002). Survival discharge was associated with higher 10 minutes Apgar scores (p < 0.001); higher blood pH and base excess (both p < 0.001); lower Thompson scores (at admission and after 24 hours of cooling; both p < 0.001); lower heart rates at initiating cooling (p = 0.003) and after 24 hours of cooling (p < 0.001) and lower average values after 3-72 hours of cooling (p < 0.001); higher body temperature at admission (p < 0.001); and lower body temperature after 24 hours and lower mean values after 3-72 hours of cooling (both p < 0.001). Survival discharge was best explained by higher blood pH (p < 0.05), higher body temperature at admission (p < 0.01), and lower body temperature and heart rate after 24 hours of cooling (p < 0.01 and <0.001, respectively). Lower heart rate, higher body temperature at admission, and lower body temperature during cooling were associated with favorable short-term outcomes.
KW - body temperature
KW - heart rate
KW - selective-head cooling
KW - therapeutic hypothermia
KW - whole-body cooling
UR - http://www.scopus.com/inward/record.url?scp=85062712951&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85062712951&partnerID=8YFLogxK
U2 - 10.1089/ther.2018.0019
DO - 10.1089/ther.2018.0019
M3 - Article
C2 - 30230963
AN - SCOPUS:85062712951
SN - 2153-7658
VL - 9
SP - 76
EP - 85
JO - Therapeutic hypothermia and temperature management
JF - Therapeutic hypothermia and temperature management
IS - 1
ER -